SEGMENT INFORMATION

12 Months Ended

Dec. 31, 2012

SEGMENT INFORMATION [Abstract]

SEGMENT INFORMATION

NOTE 12 - SEGMENT INFORMATION

The Company's reportable segments are strategic businesses that offer products and services to different markets. The Company presently has three segments: Specialty Products; Food, Pharma & Nutrition; and Animal Nutrition & Health. The Specialty Products segment provides specialty-packaged chemicals for use in healthcare and other industries. Human choline nutrient products, pharmaceutical products and encapsulated products are reported in the Food, Pharma & Nutrition segment. This segment provides microencapsulation solutions to a variety of applications in food, pharmaceutical and nutritional ingredients to enhance performance of nutritional fortification, processing, mixing, packaging applications and shelf-life. The Animal Nutrition & Health segment is in the business of manufacturing and supplying choline chloride, an essential nutrient for animal health, to the poultry and swine industries. In addition, certain derivatives of choline chloride are also manufactured and sold into industrial applications and are included in this segment. Chelated minerals and specialty nutritional products for the animal health industry are also reported in this segment. The Company sells products for all segments through its own sales force, independent distributors, and sales agents. The accounting policies of the segments are the same as those described in the summary of significant accounting policies.

Business Segment Net Sales:

	2012		2011		2010
Specialty Products	$	49,990	$	47,851	$	42,239
Food, Pharma & Nutrition		44,070		42,525		41,994
Animal Nutrition & Health		216,333		201,491		170,838
Total	$	310,393	$	291,867	$	255,071

Business Segment Earnings Before Income Taxes:

	2012		2011		2010
Specialty Products	$	20,332	$	18,636	$	15,944
Food, Pharma & Nutrition		11,335		11,113		9,748
Animal Nutrition & Health		28,110		26,476		24,078
Interest and other income		67		513		361
Total	$	59,844	$	56,738	$	50,131

Depreciation/Amortization:

	2012		2011		2010
Specialty Products	$	1,369	$	1,291	$	1,071
Food, Pharma & Nutrition		1,444		1,486		1,551
Animal Nutrition & Health		6,828		6,514		5,937
Total	$	9,641	$	9,291	$	8,559

Business Segment Assets:

	2012		2011		2010
Specialty Products	$	26,685	$	25,618	$	25,113
Food, Pharma & Nutrition		18,395		17,319		17,930
Animal Nutrition & Health		121,615		108,410		106,667
Other Unallocated		145,850		120,370		78,914
Total	$	312,545	$	271,717	$	228,624

Other unallocated assets consist of certain cash, receivables, prepaid expenses, equipment and leasehold improvements, net of accumulated depreciation, and deferred income taxes, which the Company does not allocate to its individual business segments.

Capital Expenditures:

	2012		2011		2010
Specialty Products	$	836	$	1,034	$	334
Food, Pharma & Nutrition		924		403		1,390
Animal Nutrition & Health		12,123		5,175		5,833
Total	$	13,883	$	6,612	$	7,557

Geographic Revenue Information:

	2012		2011		2010
United States	$	207,490	$	191,204	$	170,949
Foreign Countries		102,903		100,663		84,122
Total	$	310,393	$	291,867	$	255,071

Geographic Area Data – Long-Lived Assets (excluding intangible assets):

	2012		2011		2010
United States	$	41,183	$	33,511	$	32,754
Italy		11,542		10,771		10,634
Total	$	52,725	$	44,282	$	43,388